Expression of nuclear proto-oncogenes in isoproterenol-induced cardiac hypertrophy

J Mol Cell Cardiol. 1993 Nov;25(11):1325-37. doi: 10.1006/jmcc.1993.1145.

Abstract

Rat hearts infused with the beta-adrenergic agonist isoproterenol were examined for the expression of several nuclear proto-oncogenes (c-fos, fosB, c-jun, junB, and junD) and the immediate early gene Egr-1. During the first 24 h after the start of infusion, a strong but transient expression of c-fos was observed. Expression of c-jun and junD were not elevated whereas junB was. By using specific antagonists to the alpha- (prazosin) and beta-adrenergic receptor (propranolol), a beta-adrenoceptor-specific blockade of the isoproterenol-mediated nuclear response was demonstrated. In situ hybridization localized c-fos expression to cardiac myocytes. Labelling was distributed focally in the left and right ventricles, and was strong and homogeneous in the atria. In contrast to beta-adrenergic stimulation, alpha-adrenoceptor stimulation with phenylephrine and norepinephrine caused the induction of c-jun and Egr-1 in addition to the proto-oncogenes induced by isoproterenol. Thus distinct programs of early response gene expression were expressed in response to alpha- versus beta-adrenergic stimulation.

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Blotting, Northern
  • Cardiomegaly / chemically induced
  • Cardiomegaly / metabolism*
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism*
  • DNA Probes
  • Gene Expression / drug effects
  • Genes, fos / drug effects
  • Genes, fos / physiology*
  • Genes, jun / drug effects
  • Genes, jun / physiology*
  • In Situ Hybridization
  • Isoproterenol / pharmacology
  • Male
  • Rats
  • Rats, Wistar

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic beta-Agonists
  • DNA Probes
  • Isoproterenol